Clinical Trial Update: Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

The Phase 1 trial of Minnelide in adults with relapsed or refractory acute myeloid leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Minnelide (minnelide)

Snippet

Sponsor: Justin Watts | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: WITHDRAWN